Skip to main content
OpenTrials
Completed

NCT Number: NCT05512546

The Prevention of Thromboembolic Complications Associated With Coil Embolization

Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thromboembolic Stroke Aspirin Clopidogrel Coil Embolization Prevention

Age range

45 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Umair Rasheed

Lahore, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All the patients enrolled in the study underwent MRI and Angiography.
  • Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI.

Exclusion criteria

  • Patients with any history of sensitivity or reaction to aspirin, or any contraindication for MRI, were excluded from the study.

Treatment and study plan

Aspir-Low Pill

Drug

patients were prescribed 75 mg/day of either aspirin

Primary outcomes

  1. High Intensity Areas

    Time frame: at 24 hours

    post procedural

  2. High Intensity Areas

    Time frame: 3 months

    Post Procedural

Secondary outcomes

  1. High Intensity Areas

    Time frame: at 6 months

    Post procedural

Sponsors and collaborators

Lead sponsor

Muhammad Hassan

Other

Registry information

Official study title

Coil Embolization and Thromboembolic Complications in Patients With Ruptured Aneurysms

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Aug 23, 2022
Registry last updated
Aug 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.